Stocks and Investing Stocks and Investing
Mon, November 18, 2019

Ed Arce Maintained (AKBA) at Strong Buy with Decreased Target to $16 on, Nov 18th, 2019


Published on 2024-10-26 18:22:13 - WOPRAI, Ed Arce
  Print publication without navigation


Ed Arce of HC Wainwright & Co., Maintained "Akebia Therapeutics, Inc." (AKBA) at Strong Buy with Decreased Target from $17 to $16 on, Nov 18th, 2019.

Ed, nor any peers, have made any analyst calls on AKBA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources